@FierceMedDev: ICYMI yesterday: Optos, NHS and academia in $16M partnership for eye disease diagnostic. Article | Follow @FierceMedDev
@VarunSaxena2: Larry Wood of Edwards "Everybody's embarrassed that we were the 43rd country to get TAVR." Around same time as Brazil, Albania. | Follow @VarunSaxena2
@EmilyWFierce: Scalability and cost could be potential hurdles to bringing experimental CAR T-cell therapies to patients. More from the WSJ | Follow @EmilyWFierce
@MichaelGFierce: From our Women in Biotech Feature: Adelene Perkins of $INFI says, "Our endeavor is by definition a team sport." More | Follow @MichaelGFierce
> Siemens partnered with NineSigma's open innovation and social media site NineSight to encourage international research collaboration. Release
> There is now a blood test to identify people at risk of atrial fibrillation and stroke, thanks to researchers at Sweden's Lund University. Release
> Ireland's early-stage startup Embo Medical focused on developing technology to shut down blood flow in blood vessels, raised €3 million ($3.78 million) in seed funding. News
> The first U.S. patient has been successfully treated in Claret Medical's Sentinel Cerebral Protection System (CPS) trial to evaluate the role of cerebral protection during transcatheter aortic valve replacement. Release
Biotech News
@FierceBiotech: Every year Women in Biotech gets a ton of readers, and this issue is no exception. Trending nicely. Report | Follow @FierceBiotech
@JohnCFierce: In a surprise move, Bristol-Myers drops U.S. approval plans for hep C drug. News | Follow @JohnCFierce
@DamianFierce: CRO INC Research files for a $150M IPO, following in the footsteps of $Q, $CTLT and PRA. SEC filing | Follow @DamianFierce
@EmilyMFierce: Programmed antibiotics kill drug-resistant bacteria. More from FierceBiotech Research | Follow @EmilyMFierce
> Another CRO heads to Wall Street as INC swings for $150M. Report
> Bellicum puts up $50M for Ariad's R&D tech. Item
> Positive PhIII PONV study brings little Acacia to a crossroads. Story
> With help from Eli Lilly, TVM pushes its build-to-buy fund to $201M. News
Pharma News
@FiercePharma: Top-read special report Monday: Top 10 pharma companies by employees - 2014. Feature | Follow @FiercePharma
@CarlyHFierce: One more time: Our latest special report, Top women in biotech 2014. Good stuff right here. Feature | Follow @CarlyHFierce
> Report: Financial conflicts sway studies of flu fighters Tamiflu and Relenza. More
> Sovaldi may be cost-effective, but the U.K. can't afford it, documents say. Article
Biotech Research News
> NIH doles out first $46M round of BRAIN Initiative grants. Report
> Gene therapy technique could treat rare lung disease. More
> Programmed antibiotics kill drug-resistant bacteria. Story
> Ebola genome browser launched to aid drug discovery. Article
> $19M in FDA grants will support rare disease research. Item
Pharma Manufacturing News
> Cipla works with partner to build a manufacturing plant in Iran. More
> West Pharmaceutical confirms it's building $126M facility in Ireland. Story
> Patheon to add almost 500 jobs over 5 years as it expands in NC. Article
> India's IPCA buys plant as it deals with FDA issues. Item
> New FDA concerns arise for Hospira plant in Australia. Report